Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04BUH
|
|||
Former ID |
DCL000753
|
|||
Drug Name |
Cizolirtine
|
|||
Synonyms |
Cizolirtine [INN]; N,N-dimethyl-2-[(2-methylpyrazol-3-yl)-phenylmethoxy]ethanamine; N,N-dimethyl-2-[(R)-(2-methylpyrazol-3-yl)-phenylmethoxy]ethanamine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Neuropathic pain [ICD-11: 8E43.0] | Phase 2 | [1] | |
Therapeutic Class |
Analgesics
|
|||
Company |
Esteve Laboratories
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H21N3O
|
|||
Canonical SMILES |
CN1C(=CC=N1)C(C2=CC=CC=C2)OCCN(C)C
|
|||
InChI |
1S/C15H21N3O/c1-17(2)11-12-19-15(13-7-5-4-6-8-13)14-9-10-16-18(14)3/h4-10,15H,11-12H2,1-3H3
|
|||
InChIKey |
DCMJBKFKXGPPMT-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 142155-43-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Calcitonin gene-related peptide 1 (CALCA) | Target Info | Inhibitor | [1] |
Reactome | G alpha (s) signalling events | |||
Calcitonin-like ligand receptors | ||||
WikiPathways | Myometrial Relaxation and Contraction Pathways | |||
Endothelin Pathways | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.